SITE007-0138

SITE007 (JPN) › SITE007-0138

SITE007-0138

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-02-09

enrolled

AEs

4

Serious

1

Dropout signal

–

Adverse events

4

Grade 4 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-02-26 (study day 189); relationship: RELATED; serious criteria: life-threatening

severe serious under_review

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 173); relationship: not assessed

mild assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-25 (study day 65); relationship: not assessed

moderate assessed

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-10-25 (study day 65); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.